News
Filtrar por
Press Release
VaxThera, GC Biopharma and RIGHT Foundation Advance Influenza Vaccine Technology Transfer in Colombia
The project brings together international funding, proven vaccine expertise and local capabilities to strengthen vaccine manufacturing in Colombia and Latin America.
More information
Press Release
EIB, European Commission and VaxThera boost Latin America’s vaccine capacity by up to 250 million doses a year
The financing will support the expansion of an integrated manufacturing facility, enabling VaxThera to produce up to 250 million doses per year.
More information
Press release
VaxThera and Codagenix Partner to Advance a Next Generation Yellow Fever Vaccine
VaxThera will further advance Syn17D-YF, the world’s first fully synthetic yellow fever vaccine candidate designed for modern cell-culture manufacturing.
More information
Statement
VaxThera and Hetero announce strategic alliance to expand access to high-cost biologic therapies
Collaboration begins with three monoclonal antibodies and establishes a pathway toward technology transfer and local production in Colombia for Latin America
More information
Noticia
VaxThera and Serum Institute of India Announce a Strategic Collaboration to Strengthen Vaccine Development and Health Security in Colombia
This collaboration represents a historic step forward for Colombia. Together, VaxThera and the Serum Institute of India will launch a collaborative program.
More information
Press release
VaxThera, a SURA Company Created in Colombia for the Research and Development of Vaccines for Latin America
Understanding Latin America’s need of self-sufficiency in order to face future pandemics, and with the preservation of life as a priority, we have created VaxThera: a SURA Company expert in the research, development and commercialization of vaccines in Colombia and the region.
More information
Comunicado
Colombia avanza en la búsqueda de su soberanía sanitaria, gracias a la construcción de la planta de vacunas de VaxThera
Desde VaxThera estamos comprometidos con la soberanía sanitaria de Colombia donde hace más de 20 años no se producen vacunas.
More information
Press release
VaxThera to start construction of a vaccine production and Fill-and-finish plant in Colombia
VaxThera, a biotechnology company focused on research, development, and production of vaccines and other biologicals, has announced that its 35,000 m² production and bottling plant will be located in Rionegro, a municipality in the east of Antioquia. The plant will have the highest technological and human talent standards and will create over 500 jobs to support local and regional talent.
More information